HanchorBio (TPE:7827) Total Liabilities: NT$384.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:7827 HanchorBio Inc TPE:7827
9 GF Score
Price NT$156.00
View Full Analysis

What is HanchorBio Total Liabilities?

HanchorBio TPE:7827 -0.32% 9 Total Liabilities is NT$384.1 Mil as of Mar. 2026. GuruFocus rates TPE:7827 with a GF Score™ of 9/100.

HanchorBio's Total Liabilities for the quarter that ended in Mar. 2026 was NT$384.1 Mil.

HanchorBio's quarterly Total Liabilities increased from Sep. 2025 (NT$261.43 Mil) to Dec. 2025 (NT$302.36 Mil) and increased from Dec. 2025 (NT$302.36 Mil) to Mar. 2026 (NT$384.11 Mil).

HanchorBio's annual Total Liabilities declined from Dec. 2023 (NT$1,938.42 Mil) to Dec. 2024 (NT$310.67 Mil) and declined from Dec. 2024 (NT$310.67 Mil) to Dec. 2025 (NT$302.36 Mil).

HanchorBio Total Liabilities Historical Data

* Premium members only.

The historical data trend for HanchorBio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HanchorBio Total Liabilities Chart

HanchorBio Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Liabilities
1,227.83 1,938.42 310.67 302.36

HanchorBio Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only 0.00 259.50 261.43 302.36 384.11
TPE:7827
9GF Score
HanchorBio Inc TPE:7827
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HanchorBio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

HanchorBio's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=302.358+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=302.4

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1171.598-869.24
=302.4

HanchorBio's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=384.114+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=384.1

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=965.156-581.042
=384.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$384.1 Mil mean?
HanchorBio (TPE:7827) has a Total Liabilities of NT$384.1 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for HanchorBio and its competitors.
Is HanchorBio's Total Liabilities too high?
HanchorBio's current Total Liabilities is NT$384.1 Mil. Overall, HanchorBio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does HanchorBio's Total Liabilities compare to VRTX and REGN?
HanchorBio's Total Liabilities of NT$384.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for HanchorBio and its competitors. HanchorBio's current Total Liabilities is NT$384.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HanchorBio stock overvalued right now?
HanchorBio (TPE:7827) has a current Total Liabilities of NT$384.1 Mil. The current Total Liabilities is NT$384.1 Mil. HanchorBio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For HanchorBio (TPE:7827), the current Total Liabilities is NT$384.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HanchorBio Business Description

Address Sector 1, Tiding Boulevard, 5th Floor, No. 1, Neihu District, Taipei, TWN, 114
HanchorBio Inc through its subsidiaries, is conducting research and development of new anti-cancer drugs, utilizing an Fc-based biopharmaceutical platform technology to reactivate the immune system in the fight against disease. The core technology of HanchorBio is the FBDB (Fc-Based Designer Biologics) platform, which focuses on the development of next-generation immuno-oncology fusion protein therapeutics. This platform utilizes the antibody Fc region as a backbone, onto which various engineered anti-cancer molecules are constructed through protein engineering. Combined with AI-assisted drug design capabilities, this technology is dedicated to overcoming key challenges in tumor immunotherapy.
9GF Score

Get the complete analysis for TPE:7827

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$156.00
Price